Leerink Partnrs Cuts Earnings Estimates for Cardinal Health

Cardinal Health, Inc. (NYSE:CAH) – Equities research analysts at Leerink Partnrs cut their Q4 2025 earnings per share estimates for shares of Cardinal Health in a research note issued on Thursday, May 1st. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $2.00 for the quarter, down from their prior forecast of $2.04. The consensus estimate for Cardinal Health’s current full-year earnings is $7.95 per share. Leerink Partnrs also issued estimates for Cardinal Health’s FY2026 earnings at $9.11 EPS, FY2027 earnings at $9.99 EPS and FY2028 earnings at $10.94 EPS.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Cardinal Health’s quarterly revenue was up .0% compared to the same quarter last year. During the same period last year, the company earned $2.08 earnings per share.

A number of other analysts also recently issued reports on the stock. Bank of America raised their price target on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Friday, April 11th. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and upped their price target for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Mizuho boosted their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a report on Monday, March 31st. Wells Fargo & Company boosted their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Finally, UBS Group lifted their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the company a “buy” rating in a report on Tuesday, April 29th. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $144.71.

Cardinal Health Stock Performance

NYSE:CAH opened at $149.59 on Monday. Cardinal Health has a one year low of $93.17 and a one year high of $150.12. The stock has a market cap of $36.14 billion, a PE ratio of 27.91, a P/E/G ratio of 1.49 and a beta of 0.61. The stock has a 50 day moving average price of $132.38 and a 200 day moving average price of $125.16.

Institutional Investors Weigh In On Cardinal Health

Hedge funds have recently made changes to their positions in the business. Norges Bank acquired a new stake in shares of Cardinal Health in the 4th quarter worth $246,748,000. Marshall Wace LLP lifted its position in Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock valued at $372,756,000 after purchasing an additional 1,913,892 shares during the period. Castlekeep Investment Advisors LLC acquired a new stake in Cardinal Health in the fourth quarter valued at about $141,963,000. GAMMA Investing LLC increased its position in Cardinal Health by 17,589.1% during the 1st quarter. GAMMA Investing LLC now owns 964,941 shares of the company’s stock worth $132,940,000 after purchasing an additional 959,486 shares during the period. Finally, Junto Capital Management LP purchased a new position in shares of Cardinal Health during the 4th quarter worth approximately $92,811,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.